{
  "ticker": "UNCY",
  "company_name": "Unicycive Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06218290",
      "title": "A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on Dialysis",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Chronic Kidney Disease Requiring Chronic Dialysis",
      "start_date": "2023-12-15",
      "completion_date": "2024-05-29",
      "enrollment": 0,
      "sponsor": "Unicycive Therapeutics, Inc"
    }
  ],
  "summary": {
    "total_trials": 1,
    "by_phase": {
      "PHASE2": 1
    },
    "by_status": {
      "COMPLETED": 1
    },
    "active_trials": 0,
    "completed_trials": 1,
    "conditions": [
      "Chronic Kidney Disease Requiring Chronic Dialysis"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T13:12:00.671881",
    "search_query": "Unicycive Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Unicycive+Therapeutics,+Inc."
  }
}